HYCAMTIN 1mg and 4mg solution
*Company:
Novartis Ireland LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 03 July 2023
File name
REG PIL_Hycamtin 1mg_4mg Powdr Conc_Solution _Infusion_PF22-0179_Jan2023_IPHA.pdf
Reasons for updating
- Change to section 6 - marketing authorisation number
- Change to section 6 - date of revision
Updated on 22 June 2023
File name
Hycamtin Solution_REG SPC_PF22-0179_MAT transfer Nov 2022.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 06 September 2022
File name
REG PIL_Hycamtin 1mg_4mg Powdr Conc_Solution _Infusion_PF22-0160_Sept_2022_IPHA.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 14 September 2021
File name
REG_PIL_Hycamtin-IA-ATC+UK_NI_LYVI_IPHA.pdf
Reasons for updating
- Change to date of revision
Updated on 14 September 2021
File name
Hycamtin Solution_REG SPC_IPHA_Sep2021.pdf
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 29 July 2021
File name
Hycamtin Solution_REG PIL_PF21-0181_07.06.2021_IPHA.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 09 November 2020
File name
Hycamtin_solution_REG_SmPC_PF20-0243_IPHA.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 09 November 2020
File name
Hycamtin Infusion_REG PIL_PF 19-0033_IPHA.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 13 August 2020
File name
Hycamtin Infusion_REG PIL_PF 19-0033_IPHA.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - manufacturer
Updated on 17 December 2019
File name
Hycamtin Infusion_REG PIL_PF 19-0033_IPHA.pdf
Reasons for updating
- Improved presentation of PIL
Updated on 28 March 2019
File name
Hycamtin_solution_REG_SmPC_PF18-0098_IPHA.pdf
Reasons for updating
- File format updated to PDF
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 05 November 2018
File name
Hycamtin Lyvi_REG PIL9297_R91_IPHA.pdf
Reasons for updating
- Change to section 6 - marketing authorisation number
Updated on 21 May 2018
File name
Hycamtin_solution_REG_SmPC_PF18-0098_Clean.docx
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 29 January 2018
File name
PIL_9170_490.pdf
Reasons for updating
- New PIL for new product
Updated on 29 January 2018
Reasons for updating
- Change to section 4 - possible side effects
- Improved presentation of PIL
Updated on 10 January 2018
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 11 October 2017
Reasons for updating
- Change to section 6 - marketing authorisation number
- Change to section 6 - date of revision
Updated on 25 May 2016
Reasons for updating
- Change to marketing authorisation holder
Updated on 16 November 2015
Reasons for updating
- Previous version of PIL reinstated
Updated on 06 October 2014
Reasons for updating
- Addition of information on reporting a side effect.
- Change to date of revision
- Transfer of Marketing Authorisation Holder
Updated on 06 January 2014
Reasons for updating
- Change to side-effects
Updated on 30 August 2013
Reasons for updating
- Change of distributor details
Updated on 07 February 2011
Reasons for updating
- Change to side-effects
Updated on 07 April 2009
Reasons for updating
- Change to warnings or special precautions for use
- Change to dosage and administration
- Change to appearance of the medicine
- Change to side-effects
- Change to packaging
Updated on 21 August 2008
Reasons for updating
- Change to information about pregnancy or lactation
Updated on 12 June 2008
Reasons for updating
- Change to warnings or special precautions for use
Updated on 04 April 2007
Reasons for updating
- Change to side-effects
Updated on 04 August 2005
Reasons for updating
- Improved electronic presentation
Updated on 28 October 2004
Reasons for updating
- New PIL for medicines.ie